Yu, Qian https://orcid.org/0000-0001-9774-9226
Li, Peizi
Jain, Satvik
Khan, Abdul
Steiner, Joseph
Liao, Chih-Yi
Franses, Joseph
Pillai, Anjana
Fung, John
Millis, J Michael
Navuluri, Rakesh
Zangan, Steven
Funaki, Brian
Hart, John
Ahmed, Osman
Van Ha, Thuong
Article History
Received: 15 April 2026
Accepted: 4 June 2026
First Online: 2 July 2026
Declarations
:
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of University of Chicago.
: OA reported receiving personal fees from Argon Medical, Penumbra, Medtronic, Johnson & Johnson, and Boston Scientific and grants from Canon Medical, outside the submitted work. AP is on the medical advisory board for Eisai Inc., Exelixis, Genentech, AstraZeneca, and Replimune. JF receives consulting fees from Eisai, Foundation Medicine, Genentech, and Guardant Health, as well as institutional research support from Abbvie, Alnylam, Genentech, Iterion Therapeutics, and Omega Therapeutics.The remaining authors have no conflicts to report.
: This is an observational study. Informed consent was waived by the IRB of University of Chicago.
: This is an observational study. Informed consent was waived by the IRB of University of Chicago.
: None.